Adult height and glucose tolerance: a re-appraisal of the importance of body mass index

Diabetic Medicine

Volumn 34, Issue 8, 2017, Pages 1129-1135

  Rehunen, S K J ^a,b   Kautiainen, H ^c,d,e   Eriksson, J G ^c,d,f   Korhonen, P E ^b  

^a Satakunta Hospital District   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ALCOHOL USE DISORDERS IDENTIFICATION TEST; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL DISTRIBUTION; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; POPULATION RESEARCH; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; COHORT ANALYSIS; ETHNOLOGY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH SURVEY; MASS SCREENING; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; RURAL HEALTH; SEX FACTOR;

ADIPOSITY; AGED; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OVERWEIGHT; RISK FACTORS; RURAL HEALTH; SEX FACTORS;

EID: 85019751852     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13382     Document Type: Article

References (18)

1. Emerging Risk Factors Collaboration. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 2012; 41: 1419–1433.
2. Schmidt M, Bøtker HE, Pedersen L, Sørensen HT. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Eur J Epidemiol 2014; 29: 111–118.
3. Lee CM, Barzi F, Woodward M, Batty GD, Giles GG, Wong JW et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women. Int J Epidemiol 2009; 38: 1060–1071.
4. Njolstad I, Arnesen E, Lund-Larsen PG. Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark study. Am J Epidemiol 1998; 147: 49–58.
5. Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE. Differences in height explain gender differences in the response to the oral glucose tolerance test: the AusDiab study. Diabet Med 2008; 25: 296–302.
6. Janghorbani M, Amini M. Effects of gender and height on the oral glucose tolerance test: the Isfahan diabetes prevention study. Rev Diabet Stud 2008; 5: 163–170.
7. Færch K, Borch-Johnsen K, Vaag A, Jørgensen T, Witte DR. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 2010; 53: 858–865.
8. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.
9. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473–481.
10. WHO. Denition, Diagnosis and Classication of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classication of Diabetes Mellitus. Geneva: WHO, 1999.
11. Vistisen D, Witte DR, Tabak AG, Brunner EJ, Kivimäki M, Færch K. Sex differences in glucose and insulin trajectories prior to diabetes diagnosis: the Whitehall II study. Acta Diabetol 2014; 51: 315–319.
12. Williams JW, Zimmet PZ, Shaw JE, de Courten MP, Cameron AJ, Chitson P et al. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med 2003; 20: 915–920.
13. Rathmann W, Strassburger K, Giani G, Döring A, Meisinger C. Differences in height explain gender differences in the response to the oral glucose tolerance test. Diabet Med 2008; 25: 1374–1375.
14. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009; 32: 157–163.
15. Bogardus C, Lillioja S, Mott D, Reaven GR, Kashiwagi A, Foley JE. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 1984; 73: 800–805.
16. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397–405.
17. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42: 1050–1054.
18. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 1998; 21: 1236–1239.